Keysight (KEYS) Q3 2026 Earnings Call Transcript

Keysight reported fiscal Q3 revenue of $1.85B (+36% YoY) and orders of $2.09B (+56% YoY), alongside non-GAAP EPS of $3.07 (+79% YoY) and gross margin of 69%. Operating margin rose 820 bps to 33.2%, and free cash flow increased to $403M from $291M in Q3’25, with $210M of share repurchases at an average $326/share. The company raised guidance with Q4 revenue of $1.93B–$1.95B (+37% YoY at midpoint) and full-year 2026 EPS growth of ~60%, while flagging supply-chain availability as the key near-term constraint to converting demand into revenue.

Analysis

The market should read this as a confirmation that KEYS is no longer just a lab-tool cyclical; it is becoming a toll booth on multiple high-complexity buildouts. The key mechanism is test intensity: as AI architectures fragment into heterogeneous compute, optics, and protocol layers, validation spend rises faster than end-market unit growth, which expands wallet share for KEYS even if hardware shipment timing is lumpy. That creates a favorable mix shift for margins over 6-18 months, but the near-term revenue conversion still depends on constrained third-party components, so bookings can outrun recognized sales for several quarters.

The second-order winners are hyperscale-adjacent suppliers and semiconductor ecosystem vendors that need higher qualification throughput, but the losers are smaller transceiver, switch, and module vendors that face more expensive design cycles and longer time-to-ramp. That dynamic can actually slow broad-based supply response in AI infrastructure, extending the duration of KEYS demand while pushing some customers to over-order test capacity as insurance. The biggest near-term risk is that investors extrapolate order strength into revenue too aggressively; the company itself is signaling that supply, not demand, is the governor.

Contrarian view: the move may be underdone structurally but overdone tactically. The secular 6G and AI narrative is real, yet most of the incremental revenue is still ahead of us, not in the next quarter; the stock can re-rate on the story, but the operating bridge into FY27 will likely be less linear because the current-year profit base is flattered by non-recurring items. What would falsify the bull case is a Q1/FY27 print where orders remain strong but gross margin or backlog conversion disappoints due to persistent part shortages, or if the new product refresh fails to translate into share gains in wireline and EISG.

Key Decisions for Investors

• Add KEYS on weakness over the next 1-3 sessions rather than chase strength; the better entry is a pullback after the earnings gap if the market focuses on revenue conversion lag rather than orders. Risk/reward remains favorable as long as the stock holds above the post-earnings breakout zone and management keeps orders above $2B.
• Pair trade: long KEYS / short VIAV over 1-3 months. KEYS has broader exposure to AI, optical, and 6G validation spending, while VIAV should benefit less from the same complexity trade; this expresses the structural test-intensity theme with less market beta.
• For a 6-12 month view, use a call spread in KEYS rather than outright stock if you want convexity to the AI/6G roadmap but want to limit exposure to supply-chain slippage. Favors a structure that benefits if the stock re-rates on FY27 visibility without requiring flawless revenue conversion.
• Set an alert on FY27 guidance and gross margin: if management cannot keep gross margin near the high-60s or if backlog keeps rising faster than revenue for two more quarters, trim the position because the market will eventually punish deferred revenue conversion.
• Avoid shorting KEYS purely on 'this quarter was too good'; the cleaner bearish expression is a relative short against a less leveraged test-equipment peer only if the supply bottleneck worsens and management starts downgrading conversion assumptions.